Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsReiterationPrice Target
Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.
Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.